Un enfoque holístico e integrado de la implantación de los servicios farmacéutico cognitivos
Palabras clave:
Implantación, Servicios cognitivos farmacéuticos, Farmacia comunitaria, Gestión del cambioResumen
La Farmacia Comunitaria forma parte del sistema de salud. Este sistema actualmente se encuentrasometido a presiones económicas y debe afrontar cambios en la demanda tanto de los consumidorescomo de los gobiernos. La respuesta de la profesión farmacéutica está dirigida a orientar su prácticahacia el paciente y a implantar servicios cognitivos farmacéuticos (CPS). En distintos países estosservicios tiene objetivos similares aunque presentan diferencias en el énfasis de los servicios, en susdefiniciones, denominaciones y en la utilización de diferentes herramientas. Sin embargo, todos ellospueden clasificarse utilizando un amplio modelo jerárquico que se basa en la toma de decisionesclínicas y en la amplitud del cambio requerido. (Box 1). Los retos que debe afrontar la profesión estánrelacionados con el desarrollo de un nuevo modelo de farmacia orientado al paciente que afecta a laspolíticas de salud, a la formación e investigación, a la evolución de los mercados, a los abordajes delcambio tanto a nivel individual como organizacional, y a la implantación de CPS. Estos temas y lainvestigación en práctica farmacéutica que se ha venido realizando con anterioridad han sidosintetizados para proporcionar una plataforma para el cambio que pueda guiar un planteamientoholístico e integrado de implantación de CPS. Conceptualmente la implantación de CPS puedeenmarcarse en seis niveles: clínico, provisión de servicios, farmacia comunitaria, organizaciónprofesional, gobierno y agentes implicados (Figura 1). La experiencia reciente relacionada con laimplantación de servicios ha mostrado la aplicación de programas de implantación que han incluidouno o dos de estos niveles en lugar de haber utilizado un abordaje holístico. Por ello se ha desarrolladoun modelo concéntrico para ilustrar la implantación de CPS dentro del planteamiento integrado yholístico necesario para apoyar el cambio En España se ha desarrollado un programa (conSIGUE) quepretende integrar los seis niveles con el objetivo de apoyar la implantación y evaluación de un CPS, elservicio de seguimiento farmacoterapéutico.Descargas
Citas
Cipolle R, Strand L, Morley P. Pharmaceutical care practice. New York: McGraw-Hill Medical; 2004.
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-43.
World Health Organization. The World Health Report 2008: Primary health care now more than ever. Switzerland: World Health Organization; 2008:1-119. Available at: http://www.who.int/whr/2008/whr08_en.pdf [Accessed July 28, 2009].
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch. Intern. Med. 2003;163(22):2716-2724.
Wedel R, Kalischuk RG, Patterson E, Brown S. Turning Vision into Reality: Successful integration of primary healthcare in Taber, Canada. Healthcare Policy. 2007;3(1):80-95.
Crossen-Sills J, Toomey I, Doherty ME. Technology and Home Care: Implementing systems to enhance aging in place. The Nursing Clinics of North America. 2009;44(2):239-246.
UK Department of Health. Pharmacy in England: Building on strengths - delivering the future. England: UK Department of Health; 2008.
Culbertson V, Arthur T, Rhodes P, Rhodes R. Consumer preferences for verbal and written medication information. Ann Pharmacother. 1988;22(5):390-396.
Van Wijk BL. Effectiveness of Interventions by Community Pharmacists to Improve Patient Adherence to Chronic Medication: A Systematic Review. Ann Pharmacother. 2005;39(2):319-328.
Hersberger K, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes - evaluation of a campaign in Swiss community pharmacies. Pharm World Sci. 2006;28(3):171-179.
Cahill K, Stead L, Lancaster T. A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation. Drug Safety. 2009;32(2):119-135.
Hawksworth, Corlett, Wright, Chrystyn. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695-700.
Blenkinsopp A, Celino G, Bond CM, Inch J. Medicines use reviews: the first year of a new community pharmacy service. The Pharmaceutical Journal. 2007;278(24 February):218-223.
Richmond S, Morton V, Cross B, et al. Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract. 2010;60:e10-e19.
Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006;46(2):133-147.
Odedina FT, Segal R, Hepler CD. Providing pharmaceutical care in community practice. J Soc Admin Pharm. 1995;12(4):170-180.
Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496-592.
Laubscher T, Evans C, Blackburn D, Taylor J, McKay S. Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications. Can Fam Physician. 2009;55(12):e69-e75.
Chen T, de Almeida Neto A. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29(6):574-576.
George J. Supplementary Prescribing: Early Experiences of Pharmacists in Great Britain. Ann Pharmacother. 2006;40(10):1843-1850.
Guignard E, Bugnon O. Pharmaceutical Care in Community Pharmacies: Practice and Research in Switzerland. Ann Pharmacother. 2006;40(3):512-517.
Snella KA, Trewyn RD, Hansen LB, Bradberry C. Pharmacist Compensation for Cognitive Services: Focus on the Physician Office and Community Pharmacy. Pharmacotherapy. 2004;24(3):372-388.
Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother. 2005;39(11):1911-7.
Costa S, Santos C, Silveira J. Community pharmacy services in Portugal. Ann Pharmacother. 2006;40(12):2228-2234.
García del Río R. Bélgica reforma su modelo de pago a la botica priorizando el seguimiento. Correo Farmacéutico. 2010.
Bond CM. Evolution and change in community pharmacy. London: Royal Pharmaceutical Society of Great Britain; 2003. Available at: http://www.rpsgb.org.uk/pdfs/chevcommphsyn.pdf [Accessed March 22, 2009].
Benrimoj SI, Feletto E, Wilson LK. Building Organisational Flexibility to Promote the Implementation of Primary Care Service in Community Pharmacy. Canberra: Australian Government Department of Health and Ageing; 2010. Available at: http://www.guild.org.au/research/4cpa_project_display.asp?id=1865 [Accessed March 15, 2010].
Dunphy DC, Palmer IC, Benrimoj SI, Roberts AS. Change management and community pharmacy. Sydney: The University of Technology, Sydney; 2004. Available at: http://www.guild.org.au/research/project_display.asp?id=273 [Accessed February 1, 2009].
Harris W, Rivers P, Goldstein R. The potential role of community pharmacists in care management. Health Soc Care Comm. 1998;6(3):196-203.
Bernsten C, Andersson K, Gariepy Y, Simoens S. A comparative analysis of remuneration models for pharmaceutical professional services. Health Policy. 2010;95(1):1-9.
World Health Organization. The role of the pharmacist in the health care system. Tokyo, Japan: World Health Organization; 1994.
Canadian Pharmacists Association. Blueprint for pharmacy, designing the future together. Canadian Pharmacists Association; 2009.
Hamilton S, Huby G, Tierney A, et al. Mind the gap between policy imperatives and service provision: a qualitative study of the process of respiratory service development in England and Wales. BMC Health Serv Res. 2008;8:248.
Chen TF, Crampton M, Krass IK, Benrimoj SI. Collaboration between community pharmacists and GPs in innovative clinical services – a conceptual model. J Soc Admin Pharm. 1999;16(3-4):134-144.
Skomo ML, Kamal KM, Berdine HJ. A Required Course in the Development, Implementation, and Evaluation of Clinical Pharmacy Services. Am J Pharm Educ. 2008;72(5).
Fincham JE. Pharmacy Curricula and Bellwether Changes in Payment for Pharmacy Practice Services. Am J Pharm Educ. 2005;69(3):392-393.
Greene RJ, Cavell GF, Jackson SHD. Interprofessional clinical education of medical and pharmacy students. Med Educ. 1996;30(2):129-133.
Raehl CL. Changes in Pharmacy Practice Faculty 1995–2001: Implications for Junior Faculty Development. Pharmacotherapy. 2002;22(4):445-462.
Coleman CI, Schlesselman LS, Lao E, White CM. Number and Impact of Published Scholarly Works by Pharmacy Practice Faculty Members at Accredited US Colleges and Schools of Pharmacy (2001-2003). Am J Pharm Educ. 2007;71(3).
Gastelurrutia MA, Faus MJ, Fernandez-Llimos F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005;39(12):2105-2109.
Bell JS, Väänänen M, Ovaskainen H, Närhi U, Airaksinen MS. Providing Patient Care in Community Pharmacies: Practice and research in Finland. Ann Pharmacother. 2007;41(6):1039-46.
Roberts AS, Benrimoj SI, Dunphy DC, Palmer IC. Community pharmacy: Strategic change management. Sydney: McGraw-Hill Medical; 2007.
Desselle SP, Zgarrick DP. Pharmacy Management: Essentials for all practice settings. New York: McGraw Hill; 2004.
Feletto E, Wilson L, Roberts A, Benrimoj S. Flexibility in community pharmacy: a qualitative study of business models and cognitive services. Pharmacy World & Science. 2010;32(2):130-138.
Munroe WP, Rosenthal TG. Implementing Pharmaceutical Care: Evolution vs. revolution. Am Pharm. 1994;NS34(4):57-67.
Porter ME. On Competition, Updated and Expanded Edition. Updated Expaned. Harvard Business School Press; 2008.
Holland R, Nimmo C. Transitions, Part 1: Beyond pharmaceutical care. Am J Health Syst Pharm. 1999;56(17):1758-1764.
Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. J Am Pharm Assoc (Wash). 1997;NS37(5):535-542.
Elwyn G, Taubert M, Kowalczuk J. Sticky Knowledge: A possible model for investigating implementation in healthcare contexts. Implement Sci. 2007;2:44.
Greenhalgh T, Robert G, Bate P, Macfarlane F, Kyriakidou O. Diffusion of Innovations in Health Services Organisations: A systematic literature review. Oxford: Blackwell Publishing; 2005.
Golden W, Powell P. Towards a definition of flexibility: in search of the Holy Grail? Omega. 2000;28(4):373-384.
Ackoff R. Towards flexible organizations: A multidimensional design. Omega. 1977;5(6):649-662.
Volberda HW. Organizational Flexibility: Change preservation. A flexibility audit & redesign method. Groningen: Wolters-Noordhoff; 1992.
F
eletto E, Wilson LK, Roberts AS, Benrimoj SI. Measuring organizational flexibility in community pharmacy: Building the capacity to implement cognitive pharmaceutical services. Res Social Adm Pharm. 2010;In Press.
Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity to implement cognitive pharmaceutical services: Quantifying the needs of community pharmacies. Res Social Adm Pharm. 2009;In Press, Corrected Proof.
Indritz MES, Artz MB. Value Added to Health by Pharmacists. Soc Sci Med. 1999;48:647-660.
Venkataraman K, Madhavan S, Bone P. Barriers and facilitators to pharmaceutical care in rural community practice. J Soc Admin Pharm. 1997;14(4):208-219.
van Mil JWF, Schulz M, Tromp TFJD. Pharmaceutical Care, European Developments in Concepts, Implementation, Teaching, and Research: A review. Pharm World Sci. 2004;26(6):303-11.
Rossing C, Hansen EH, Krass IK. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. J Soc Admin Pharm. 2001;19(2):55-64.
Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice Change in Community Pharmacy: Quantification of facilitators. Ann Pharmacother. 2008;42(6):861-8.
Gastelurrutia MA, Benrimoj SI, Castrillon CC, et al. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci. 2009;31(1):32-9.
B
erbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced Pharmacy Services, Barriers and Facilitators in Australia's Community Pharmacies: Australia's national database project. Int J Pharm Prac. 2007;15(3):185-191.
Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing Cognitive Services in Community Pharmacy: a review of facilitators used in practice change. Int J Pharm Prac. 2006;14:163-170.
Christensen DB, Hansen RW. Characteristics of Pharmacies and Pharmacists Associated with the Provision of Cognitive Services in the Community Setting. Journal of the American Pharmaceutical Association. 1999;39(5):640-647.
Hopp TR, Klinke BO, Sorensen EW, Herborg H, Roberts AS. Implementation of cognitive pharmaceutical services in Danish community pharmacies - perceptions of strategists and practitioners. Int J Pharm Prac. 2006;14(1):37-49.
The Commonwealth of Australia. The fourth community pharmacy agreement. 2005. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/F7FBDB333D030BFFCA2570C000003A44/$File/4cpacompilation.pdf.
Pharmaceutical Society of Australia. Pharmacy is your future. Are you part of it?. Pharmaceutical Society of Australia; 2009.
M
inisterio de Sanidad y Consumo. Plan Estratégico de Política Farmacéutica para el
Sistema Nacional de Salud Español. Madrid: Ministerio de Sanidad y Consumo; 2004.
Ministerio de Sanidad y Consumo – Dirección General de Farmacia y Productos sanitarios. Consenso en Atención Farmacéutica. Ars Pharmaceutica. 2001;42(3-4):221-241.
Chapman J, Roberts M, Stokes J. Final Report: Evaluation of the Quality Care Pharmacy Program. Australia: The Pharmacy Guild of Australia; 2005. Available at: http://beta.guild.org.au/research/project_display.asp?id=281 [Accessed July 23, 2009].
B
lenkinsopp A, Tann J, Platts A, Allen J. Evaluation of feasibility and acceptability of a community pharmacy health promotion scheme - views of users and providers. Health Educ J. 2002;61(1):52-69.
Pouloudi A, Whitley EA. Stakeholder identification in inter-organizational systems: gaining insights for drug use management systems. Eur J Inf Syst. 1997;6(1):1-14.
Vuong T, Marriott JL. Potential role of the community liaison pharmacist: stakeholder views. Int J Pharm Prac. 2006;14(2):135-148.
C
hen T, de Almeida Neto A. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29(6):574-576.
Brock K.A., Doucette W.R. Collaborative Working Relationships Between Pharmacists and Physicians: An Exploratory Study. J Am Pharm Assoc. 2004;44:358-365.
Van C, Krass IK, Mitchell B. General Practitioner Perceptions of Extended Pharmacy Services and Modes of Collaboration with Pharmacists. J Pharm Prac Res. 2007;37(3):182-186.
Whitehead P, Atkin P, Krass IK, Benrimoj SI. Patient drug information and consumer choice of pharmacy. Int J Pharm Prac. 1999;7:71-79.
Gastelurrutia M, Gil de San Vicente O, Erauncetamurgil O, Odriozola I, Fernández-Llimós F. Customers’ expectations and satisfaction with a pharmacy not providing advanced cognitive services. Pharm World Sci. 2006;28(6):374-376.
Naik Panvelkar P, Saini B, Armour C. Measurement of patient satisfaction with community pharmacy services: a review. Pharm World Sci. 2009;31(5):525-537.
Hassell K, Rogers A, Noyce PR. Community pharmacy as a primary health and self-care resource: a framework for understanding pharmacy utilization. Health Soc Care Comm. 2000;8(1):40-49.
Oscanoa T. Servicio de Geriatría Hospital Almenara. Anales de la Facultad de Medicina, Universidad Nacional Mayor de San Marcos. Interacción medicamentosa en Geriatría. 2000;65:119-126.
Ministerio de Sanidad y Consumo – Dirección General de Farmacia y Productos sanitarios. Consenso sobre Atención Farmacéutica. 2002. Available at: http://www.msc.es/profesionales/farmacia/consenso/consenso.htm#indice [Accessed November 12, 2009].
Consejo General de Colegios Oficiales de Farmacéuticos. Plan Estratégico para el Desarrollo de la Atención Farmacéutica. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2003. Available at: http://www.portalfarma.com/pfarma/taxonomia/general/gp000030.nsf/voDocumentos/73CCC188B3FEE9D9C1256C4B00398D49/$File/INDICE.pdf [Accessed November 12, 2009].
Grupo de Expertos de Foro de Atención Farmacéutica. Documento de Consenso. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2008.
Sabater Hernández D, Silva Castro MM, Faus Dáder MJ. Método Dáder. Guía de Seguimiento Farmacoterapéutico. Tercera edición. Granada: Grupo de Investigación en Atención Farmacéutica; 2007.
Dualde E, Faus M, Santonja F, Fernandez-Llimos F. Effectiveness of a videoconference training course on implementing pharmacy services. Pharm World Sci. 2009;31(6):638-642.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Los artículos que se publican en esta revista están sujetos a los siguientes términos en relación a los derechos patrimoniales o de explotación:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, la cual se distribuirá con una licencia Creative Commons BY-NC-SA 4.0 que permite a terceros reutilizar la obra siempre que se indique su autor, se cite la fuente original y no se haga un uso comercial de la misma.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la fuente original de su publicación.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en repositorios institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
